Search

Your search keyword '"Openshaw, Peter J M"' showing total 259 results

Search Constraints

Start Over You searched for: Author "Openshaw, Peter J M" Remove constraint Author: "Openshaw, Peter J M" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
259 results on '"Openshaw, Peter J M"'

Search Results

1. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

2. Accelerated immune ageing is associated with COVID-19 disease severity

4. Obesity dysregulates the pulmonary antiviral immune response

5. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

6. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

7. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

8. Whole-genome sequencing reveals host factors underlying critical COVID-19

9. Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

10. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

11. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study

12. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study

13. T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

15. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

18. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection

19. Whole-genome sequencing reveals host factors underlying critical COVID-19

20. Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants.

21. SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study

22. Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

23. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

24. Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages

25. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

26. Implementation of corticosteroids in treating COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK:prospective observational cohort study

27. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19.

29. Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers

30. COVID-19 symptoms at hospital admission vary with age and sex

32. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

33. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study.

34. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

37. Additional file 1 of Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort

38. Genetic mechanisms of critical illness in COVID-19

39. Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK):a prospective observational study

40. Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission.

41. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

42. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

43. Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism

48. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort.

Catalog

Books, media, physical & digital resources